Clareo Health | Evaluation the Safety and Effectiveness of the GORE GDI in Adult Subjects With Primary Open-angle Glaucoma in Whom Previous Medical and Surgical Treatment Have Failed.
Evaluation the Safety and Effectiveness of the GORE GDI in Adult Subjects With Primary Open-angle Glaucoma in Whom Previous Medical and Surgical Treatment Have Failed.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gore Ophthalmic
Age
46–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of primary open-angle glaucoma (POAG) with IOP uncontrolled by medical therapy and failed surgical treatment
Medicated IOP of \>=20 mmHg
Shaffer angle grade \>= 2 in target quadrant
Area of free and mobile conjunctiva without extensive scarring or fibrosis
At least 46 years old
You may not be if
Closed-angle and secondary glaucomas
Any pathology or condition (including prior glaucoma filtration or conjunctival surgery) that prevents implantation of the study device in the target quadrant
Diagnosis of degenerative visual disorders
History of corneal transplantation, prior corneal surgery, corneal opacities inhibiting visualization, or clinically significant corneal disease pathology
Non-study eye with BCVA worse than 20/200
Pregnant or nursing women; or women of childbearing potential not using medically acceptable birth control
